| Products name |
CAS.NO |
Formula |
Inquiry |
| (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone |
189028-93-1 |
C20H18FNO4 |
Detail |
| Rink Amide Linker |
126828-35-1 |
C32H29NO7 |
Detail |
| Fmoc-OSu |
82911-69-1 |
C19H15NO5 |
Detail |
| 2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine hydrochloride (230615-52-8) |
230615-52-8 |
C11H13N.HCl |
Detail |
| 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine (230615-51-7) |
230615-51-7 |
C13H12F3NO |
Detail |
| 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine (230615-69-7) |
230615-69-7 |
C13H14F3N3O |
Detail |
| 7,8,9,10-Tetrahydro-8-(trifluoroacetyl)-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine (230615-70-0) |
230615-70-0 |
C15H12F3N3O |
Detail |
| 2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine (230615-59-5) |
230615-59-5 |
C13H10F3N3O5 |
Detail |
| Fondaparinux Sodium (114870-03-0) |
114870-03-0 |
C31H43N3Na10O49S8 |
Detail |
| Pentasaccharide N-3 Intermediate (114903-05-8) |
114903-05-8 |
C81H91N7O27 |
Detail |
| Fondaparinux intermediate A (114870-02-9) |
114870-02-9 |
C31H53N3O40S5・7Na |
Detail |
| Fondaparinux intermediate B (501092-87-1) |
501092-87-1 |
C24H17FO6 |
Detail |
| Fondaparinux intermediate C (704210-18-4) |
704210-18-4 |
C73H83N9O25 |
Detail |
| Fondaparinux intermediate E (99541-27-2) |
99541-27-2 |
C51H56N6O16 |
Detail |
| Fondaparinux intermediate F (501089-97-0) |
501089-97-0 |
C42H43N3O13 |
Detail |
2|28
0755-28351685
